These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33088577)

  • 1. Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community.
    Kniazkov S; Dube-Mwedzi S; Nikiema JB
    J Pharm Policy Pract; 2020; 13():71. PubMed ID: 33088577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid assessment of the National Regulatory Systems for medical products in the Southern African Development Community.
    Dube-Mwedzi S; Kniazkov S; Nikiema JB; Kasilo OMJ; Fortin A; Tumusiime P; Mahlangu GN; Ndomondo-Sigonda M
    J Pharm Policy Pract; 2020; 13():64. PubMed ID: 33029353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities.
    Macé C; Nikiema JB; Sarr OS; Ciza Hamuli P; Marini RD; Neci RC; Bourdillon Esteve P; Ravinetto R
    J Pharm Policy Pract; 2023 Oct; 16(1):117. PubMed ID: 37803394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pharmacovigilance guidelines in the Southern African Development Community: A document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5755. PubMed ID: 38362654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
    Roth L; Bempong D; Babigumira JB; Banoo S; Cooke E; Jeffreys D; Kasonde L; Leufkens HGM; Lim JCW; Lumpkin M; Mahlangu G; Peeling RW; Rees H; Ndomondo-Sigonda M; Stergachis A; Ward M; Nwokike J
    Global Health; 2018 Nov; 14(1):102. PubMed ID: 30382856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden.
    Funestrand H; Liu R; Lundin S; Troein M
    J Public Health (Oxf); 2019 Mar; 41(1):e95-e102. PubMed ID: 29860331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems.
    Chabalenge B; Jere E; Nanyangwe N; Hikaambo C; Mudenda S; Banda M; Kalungia A; Matafwali S
    J Med Access; 2022; 6():27550834221141767. PubMed ID: 36601496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health alerts for substandard, falsified, and unregistered medical products at the onset of the COVID-19 pandemic in the AmericasAlertas de saúde para produtos médicos abaixo do padrão, falsificados e não registrados no início da pandemia de COVID-19 nas Américas].
    Gorordo M; Rojas-Cortés R; Carino J; Vahos Zambrano J; Castro JL
    Rev Panam Salud Publica; 2024; 48():e7. PubMed ID: 38370134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substandard and falsified medical products: bibliometric analysis and mapping of scientific research.
    Sweileh WM
    Global Health; 2021 Sep; 17(1):114. PubMed ID: 34556126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring pharmacists' perspectives about substandard and falsified medical products through interviews.
    Persson A; Troein M; Lundin S; Midlöv P; Lenander C
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100421. PubMed ID: 38405083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia.
    Wagnild JM; Lee D; Jayeola B; Lukito PK; Fimbo A; Hampshire K
    Glob Health Sci Pract; 2023 Aug; 11(4):. PubMed ID: 37640491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substandard and Falsified Medicines in Myanmar.
    Sakuda M; Yoshida N; Takaoka T; Sanada T; Rahman MS; Tanimoto T; Zin T; Kimura K; Tsuboi H
    Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32204459
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review.
    Sorato MM; Davari M; Kebriaeezadeh A
    J Med Access; 2024; 8():27550834241236598. PubMed ID: 38476401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets Law.
    Olliaro E; Olliaro P; Ho CWL; Ravinetto R
    Am J Trop Med Hyg; 2020 Feb; 102(2):262-267. PubMed ID: 31746313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substandard and falsified medicines in African pharmaceutical markets: A case study from Ethiopia.
    Mengesha A; Bastiaens H; Ravinetto R; Gibson L; Dingwall R
    Soc Sci Med; 2024 May; 349():116882. PubMed ID: 38669893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.